536
Articles
12.2K
Citations
3.4
avg. Impact Factor
56
h-index

Most Cited Articles of Shandong Provincial Key Laboratory of Radiation Oncology in 2002

TitleJournalYearCitations
The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis inductionBlood2002324
Effect of treatment delay on outcome of patients with early-stage head-and-neck carcinoma receiving radical radiotherapyInternational Journal of Radiation Oncology Biology Physics200296
Results of long-term experimental studies on the carcinogenicity of formaldehyde and acetaldehyde in ratsAnnals of the New York Academy of Sciences200281
Results of long-term experimental studies on the carcinogenicity of ethylene-bis-dithiocarbamate (Mancozeb) in ratsAnnals of the New York Academy of Sciences200265
Results of long-term experimental studies on the carcinogenicity of methyl alcohol and ethyl alcohol in ratsAnnals of the New York Academy of Sciences200262
Phase I clinical and pharmacokinetic study of protein kinase C-alpha antisense oligonucleotide ISIS 3521 administered in combination with 5-fluorouracil and leucovorin in patients with advanced cancerClinical Cancer Research200239
Increased risk of parvovirus B19 infection in young adult cancer patients receiving multiple courses of chemotherapyJournal of Clinical Microbiology200228
A phase II trial of oral temozolomide in patients with metastatic renal cell cancerCancer Chemotherapy and Pharmacology200215
Gemcitabine doublets in advanced urothelial cancerSeminars in Oncology200212
Results of long-term carcinogenicity bioassays on tert-amyl-methyl-ether (TAME) and di-isopropyl-ether (DIPE) in ratsAnnals of the New York Academy of Sciences200211
Results of long-term carcinogenicity bioassay on vinyl acetate monomer in Sprague-Dawley ratsAnnals of the New York Academy of Sciences200210
Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatinAnticancer Research20029
Ramazzini Foundation cancer program: history and major projects, life-span carcinogenicity bioassay design, chemicals studied, and resultsAnnals of the New York Academy of Sciences20029
A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracilAnticancer Research20027
Silence is golden: gene hypermethylation and survival in large-cell lymphomaJournal of the National Cancer Institute20025